Posts

August 15, 2014

+
5:04 PM | A “Hit and Run” Molecular Model for Lymphoma Development
Diffuse large B-cell lymphoma (DLBCL) represents the most common human lymphoid malignancy, affecting many thousands worldwide each year. Genomic analysis can discriminate lymphomas into two major subtypes with clinical relevance: germinal center B-cells (GCB-like), or activated B-cells (ABC-like).  Current treatment regimens offer only limited overall efficacy as, relative to GCB-like ... The post A “Hit and Run” Molecular Model for Lymphoma Development appeared first on […]
+
3:24 PM | Right Turn: The creative process
I’m starting this post with an image that more or less sums up my life over the past two weeks, which has been rather intensely focused on creativity. This was the second time I traveled to Banff to be part of the Science Communications program at the Banff Centre, a very worthwhile sojourn for scientists...Read more
+
2:30 PM | Friday SNPpets
Welcome to our Friday feature link collection: SNPpets. During the week we come across a lot of links and reads that we think are interesting, but don’t make it to a blog post. Here they are for your enjoyment… RT @joe_pickrell: Great post by @Graham_Coop and @JeremyJBerg on interpreting tests for selection on polygenic traits […]
+
10:53 AM | NICE backs Gilead’s Sovaldi in hepatitis C
But health watchdog denies earlier use of Janssen’s Zytiga
+
10:51 AM | US panel backs pneumococcal vaccines for seniors
Vaccines to be provided by Merck & Co and Pfizer
+
10:32 AM | Avastin gets US green light for late-stage cervical cancer
Fifth oncology indication for Roche’s medicine
+
2:58 AM | http://feedproxy.google.com/~r/blogspot/OYklv/~3/xsOdkqhrCoI/phagocytosis-phagocyosis-is-process-of.html
PhagocytosisPhagocyosis is the process of engulfment and digestion of microorganisms performed by macrophages & microphages.The macrophages:These cells originate from bone marrow promonocytes; after circulating in blood for few hours they migrate to tissues and constitute the mononuclear phagocyte system. They have been given specific names in accordance with their residing tissues; in lungs ; alveolar macrophages, in  liver ; kupffer cells, microglial cells in brain, mesangial cells […]
+
2:58 AM | http://feedproxy.google.com/~r/blogspot/OYklv/~3/xsOdkqhrCoI/phagocytosis-phagocyosis-is-process-of.html
PhagocytosisPhagocyosis is the process of engulfment and digestion of microorganisms performed by macrophages & microphages.The macrophages:These cells originate from bone marrow promonocytes; after circulating in blood for few hours they migrate to tissues and constitute the mononuclear phagocyte system. They have been given specific names in accordance with their residing tissues; in lungs ; alveolar macrophages, in  liver ; kupffer cells, microglial cells in brain, mesangial cells […]

August 14, 2014

+
11:16 PM | Cancer Research UK calls for accuracy on Wikipedia
Appeals to healthcare community to keep online information up to date
+
11:15 PM | GE Healthcare makes changes in Asia
Olivier Loeillot appointed general manager, Asia commercial for BioProcess division
+
11:15 PM | Rebif hit again as competition bites
Merck Serono’s MS drug continues its struggle for sales in the US and Europe
+
5:03 PM | Saving heritage breeds preserves valuable traits and culture
Early in June, I booked into a bed and breakfast near Ravenscrag, Saskatchewan to work on a new writing project. The journey there ended up being a little more dramatic than I wanted – my Chevy Tracker lost a wheel on the highway near Kyle, Sask, and I ended up borrowing a car from some kind strangers for about 10 days – but the destination ended up being well worth the trouble. Jim Saville, the proprietor of the bed and breakfast, had several different heritage breeds on the […]
+
3:00 PM | FDA Explores Proprietary Name Reservation for Drug Products
A proprietary name for a drug product can be submitted for evaluation by FDA any time after the completion of Phase II studies. The ultimate approval of a proprietary name is part of the approval of the labeling of a marketing application and is limited to a “tentative approval” prior to that. Thus, it is ... continue reading
+
1:33 PM | What’s the Answer? (real time collaborative coding)
Biostars is a site for asking, answering and discussing bioinformatics questions and issues. We are members of the community and find it very useful. Often questions and answers arise at Biostars that are germane to our readers (end users of genomics resources). Every Thursday we will be highlighting one of those items or discussions here […]
+
1:07 PM | How many MiSeq owners are using the bleach protocol to minimise carryover?
A comment popped up on a post I'd written in April last year "MiSeq (and 2500) owners better read this and beware"that made me think I'd ask readers the question in the title: "how many of you are using the MiSeq bleach wash protocol? online pollsThe carryover issue led to a small residue of the last library to be run being sequenced in the subsequent run. This caused a potential problem to MiSeq users, particularly those interested in low frequency mutations. My post was prompted after some […]
+
12:59 PM | 50 musei da vedere almeno una volta nella vita
Arte, tecnologia, storia: il meglio del genio umano si trova qui, in luoghi di storico fascino o esaltante architettura contemporaneaRead more →
+
12:46 PM | Asteroidi e forze di van der Waals
Guardatela bene, quest’ombra qui a fianco: quella che s’intravede nel buio è la sagoma di1950 DA, un asteroide con un diametro medio di circa 1,3 km. Un Near Earth Object, come gli scienziati chiamano i corpi del Sistema solare la cui…Read more →
+
10:45 AM | How Ebola Kills
“That’s not Ebola!” I said to the vendor standing beside a display of boxer shorts festooned with pathogens, at a biology teachers conference a few years ago. “No, that’s Ebola. Read the tag.” “The tag’s wrong.… Read the restThe post How Ebola Kills appeared first on DNA Science Blog.
+
10:44 AM | Celltrion submits biosimilar Remicade for US approval
Drug is second to be assessed by FDA under biosimilars pathway
+
10:41 AM | AZ takes asthma antibody into phase III
Tralokinumab tipped as potential blockbuster
+
10:15 AM | FDA approves Merck’s insomnia drug
Belsomra is first orexin receptor antagonist available in US
+
9:33 AM | Sanofi ships synthetic malaria jab
French manufacturer says Gates Foundation-funded venture could widen treatment
+
9:09 AM | Amgen hit as Kyprolis fails myeloma study
Inability to improve overall survival could dent expanded use prospects
+
8:29 AM | Bringing researchers and the public together for science
This an an article I wrote for SciBraai about The Science Awareness Day at UCT on Wednesday 6 August. Bringing researchers and the public together for science    
+
7:47 AM | 3D living brain sponges
Scientists create 3D living brain sponges to study the effect of brain injuries on living brain tissue. It is now possible to 3D print replacement body parts from a range of biomaterials. But the brain is difficult to engineer because neurons have to grow and form connections to make functional brain tissue. Previously people have tried to grow […]
+
3:01 AM | Swim Like a Shark
As Shark Week sinks its teeth into your TV and social media channels, from megalodon – the 50-foot-long “mega-toothed” shark that while extinct chomps on in our imaginations – to Zombie Sharks, you might not realize that we stand to learn a heck of a lot from sharks. A 6th sense—and a 7th: sharks navigate using electromagnetic fields & pressure changes http://t.co/EVYHSmVfHw #SharkWeek — pew environment (@pewenvironment) August 13, 2014 Among the many […]

August 13, 2014

+
11:17 PM | Pharma Perspectives with the HCC: Malik Akhtar on the pitching process
Bayer's category lead for agency services gives a pharma view
+
11:17 PM | Pharma Perspectives with the HCC: Ben Davies on the pitching process
Havas Health's European CEO gives an agency view
+
11:16 PM | Sanofi’s US pharma head joins Synta as CEO
Anne Whitaker also has experience at GSK
+
11:16 PM | Huntsworth CEO to step down
Lord Chadlington to leave PR group
23456789
264 Results